KAP.IL vs. VRTX

Last updated Jun 13, 2026

KAP.IL (JSC National Atomic Company Kazatomprom) and VRTX (Vertex Pharmaceuticals Incorporated) are both stocks. KAP.IL operates in Uranium (Energy), while VRTX operates in Biotechnology (Healthcare). Over the past 5 years, KAP.IL returned 24.26%/yr vs 18.18%/yr for VRTX. At a 0.04 correlation, their price movements are largely independent.

Performance

KAP.IL vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in JSC National Atomic Company Kazatomprom (KAP.IL) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, KAP.IL achieves a 24.37% return, which is significantly higher than VRTX's -1.86% return.

KAP.IL

• 1D: -0.14%
• 1M: -0.00%
• YTD: 24.37%
• 6M: 19.24%
• 1Y: 78.29%
• 3Y*: 43.43%
• 5Y*: 24.26%
• 10Y*: —

VRTX

• 1D: -0.03%
• 1M: -1.22%
• YTD: -1.86%
• 6M: -1.57%
• 1Y: -2.31%
• 3Y*: 9.16%
• 5Y*: 18.18%
• 10Y*: 17.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

KAP.IL vs. VRTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
KAP.IL JSC National Atomic Company Kazatomprom	24.37%	56.07%	-1.79%	55.12%	-17.26%	115.04%	48.04%	1.25%	13.42%
VRTX Vertex Pharmaceuticals Incorporated	-1.86%	12.58%	-1.03%	40.90%	31.50%	-7.08%	7.94%	32.13%	-4.13%

Correlation

The correlation between KAP.IL and VRTX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (5Y) Calculated over the trailing 5-year period	0.04
Correlation (All Time) Calculated using the full available price history since Nov 13, 2018	0.04

Return for Risk

KAP.IL vs. VRTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KAP.IL

KAP.IL Risk / Return Rank: 83
KAP.IL Sharpe Ratio Rank: 85
KAP.IL Sortino Ratio Rank: 81
KAP.IL Omega Ratio Rank: 80
KAP.IL Calmar Ratio Rank: 84
KAP.IL Martin Ratio Rank: 86

VRTX

VRTX Risk / Return Rank: 37
VRTX Sharpe Ratio Rank: 39
VRTX Sortino Ratio Rank: 34
VRTX Omega Ratio Rank: 35
VRTX Calmar Ratio Rank: 38
VRTX Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KAP.IL vs. VRTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for JSC National Atomic Company Kazatomprom (KAP.IL) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	KAP.IL	VRTX	Difference
Sharpe ratio: Return per unit of total volatility	1.61	-0.10	+1.71
Sortino ratio: Return per unit of downside risk	2.25	0.10	+2.15
Omega ratio: Gain probability vs. loss probability	1.29	1.02	+0.27
Calmar ratio: Return relative to maximum drawdown	2.96	-0.14	+3.10
Martin ratio: Return relative to average drawdown	8.64	-0.29	+8.94

KAP.IL vs. VRTX - Sharpe Ratio Comparison

The current KAP.IL Sharpe Ratio is 1.61, which is higher than the VRTX Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of KAP.IL and VRTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

KAP.IL vs. VRTX - Drawdown Comparison

The maximum KAP.IL drawdown since its inception was -49.67%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for KAP.IL and VRTX.

Drawdown Indicators

	KAP.IL	VRTX	Difference
Max Drawdown Largest peak-to-trough decline	-49.67%	-91.77%	+42.10%
Max Drawdown (1Y) Largest decline over 1 year	-25.44%	-23.56%	-1.88%
Max Drawdown (3Y) Largest decline over 3 years	-33.25%	-29.07%	-4.18%
Max Drawdown (5Y) Largest decline over 5 years	-49.67%	-29.07%	-20.60%
Max Drawdown (10Y) Largest decline over 10 years	—	-41.60%	—
Current Drawdown Current decline from peak	-23.90%	-13.90%	-10.00%
Average Drawdown Average peak-to-trough decline	-14.97%	-37.73%	+22.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.73%	11.30%	-2.57%

Volatility

KAP.IL vs. VRTX - Volatility Comparison

JSC National Atomic Company Kazatomprom (KAP.IL) has a higher volatility of 10.50% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.47%. This indicates that KAP.IL's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KAP.IL	VRTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.50%	7.47%	+3.03%
Volatility (6M) Calculated over the trailing 6-month period	37.79%	20.71%	+17.08%
Volatility (1Y) Calculated over the trailing 1-year period	46.83%	34.13%	+12.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.34%	28.53%	+18.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.88%	32.82%	+10.06%

Dividends

KAP.IL vs. VRTX - Dividend Comparison

KAP.IL's dividend yield for the trailing twelve months is around 3.38%, while VRTX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
KAP.IL JSC National Atomic Company Kazatomprom	3.38%	4.20%	6.85%	4.26%	6.94%	3.69%	5.15%	6.23%
VRTX Vertex Pharmaceuticals Incorporated	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both KAP.IL and VRTX in my portfolio?

KAP.IL and VRTX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.